# Solstice Advanced Materials Inc.: financial statements, quarterly

SOLS · Nasdaq · CIK 2064953 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sols.md) · [Financials](/companies/sols/financials.md) · [Filings](/companies/sols/filings.md) · [Insiders](/companies/sols/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sols/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [907](/filings/0002064953-25-000018.md) | [913 d](/filings/0002064953-26-000008.md) | [897](/filings/0002064953-26-000047.md) | [1,033](/filings/0002064953-26-000087.md) | [969](/filings/0002064953-25-000018.md) | [987 d](/filings/0002064953-26-000008.md) | [991](/filings/0002064953-26-000047.md) | [1,148](/filings/0002064953-26-000087.md) |
| Cost of revenue | $m | [575](/filings/0002064953-25-000018.md) | [608 d](/filings/0002064953-26-000008.md) | [577](/filings/0002064953-26-000047.md) | [671](/filings/0002064953-26-000087.md) | [659](/filings/0002064953-25-000018.md) | [729 d](/filings/0002064953-26-000008.md) | [675](/filings/0002064953-26-000047.md) | [778](/filings/0002064953-26-000087.md) |
| Research and development | $m | [21.0](/filings/0002064953-25-000018.md) | [21.0 d](/filings/0002064953-26-000008.md) | [22.0](/filings/0002064953-26-000047.md) | [23.0](/filings/0002064953-26-000087.md) | [26.0](/filings/0002064953-25-000018.md) | [27.0 d](/filings/0002064953-26-000008.md) | [28.0](/filings/0002064953-26-000047.md) | [25.0](/filings/0002064953-26-000087.md) |
| Selling, general and administrative | $m | [107](/filings/0002064953-25-000018.md) | [89.0 d](/filings/0002064953-26-000008.md) | [93.0](/filings/0002064953-26-000047.md) | [105](/filings/0002064953-26-000087.md) | [113](/filings/0002064953-25-000018.md) | [112 d](/filings/0002064953-26-000008.md) | [108](/filings/0002064953-26-000047.md) | [123](/filings/0002064953-26-000087.md) |
| Interest expense | $m | [3.0](/filings/0002064953-25-000018.md) | [2.0 d](/filings/0002064953-26-000008.md) | [1.0](/filings/0002064953-26-000047.md) | [2.0](/filings/0002064953-26-000087.md) | [2.0](/filings/0002064953-25-000018.md) | [23.0 d](/filings/0002064953-26-000008.md) | [29.0](/filings/0002064953-26-000047.md) | [23.0](/filings/0002064953-26-000087.md) |
| Income tax | $m | [49.0](/filings/0002064953-25-000018.md) | [42.0 d](/filings/0002064953-26-000008.md) | [47.0](/filings/0002064953-26-000047.md) | [101](/filings/0002064953-26-000087.md) | [182](/filings/0002064953-25-000018.md) | [32.0 d](/filings/0002064953-26-000008.md) | [31.0](/filings/0002064953-26-000047.md) | [42.0](/filings/0002064953-26-000087.md) |
| Net income | $m | [152](/filings/0002064953-25-000018.md) | [133 d](/filings/0002064953-26-000008.md) | [134](/filings/0002064953-26-000047.md) | [97.0](/filings/0002064953-26-000087.md) | [(35.0)](/filings/0002064953-25-000018.md) | [41.0 d](/filings/0002064953-26-000008.md) | [85.0](/filings/0002064953-26-000047.md) | [119](/filings/0002064953-26-000087.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.85](/filings/0002064953-26-000047.md) | [0.61](/filings/0002064953-26-000087.md) | not reported | not reported | [0.53](/filings/0002064953-26-000047.md) | [0.75](/filings/0002064953-26-000087.md) |
| Basic EPS | $ per share | not reported | not reported | [0.85](/filings/0002064953-26-000047.md) | [0.61](/filings/0002064953-26-000087.md) | not reported | not reported | [0.53](/filings/0002064953-26-000047.md) | [0.75](/filings/0002064953-26-000087.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [661](/filings/0002064953-26-000008.md) | not reported | not reported | [417](/filings/0002064953-25-000018.md) | [534](/filings/0002064953-26-000087.md) | [642](/filings/0002064953-26-000047.md) | [750](/filings/0002064953-26-000087.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [1,861](/filings/0002064953-26-000008.md) | not reported | not reported | [1,878](/filings/0002064953-25-000018.md) | [2,388](/filings/0002064953-26-000087.md) | [2,436](/filings/0002064953-26-000047.md) | [2,568](/filings/0002064953-26-000087.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [5,004](/filings/0002064953-26-000008.md) | not reported | not reported | [5,247](/filings/0002064953-25-000018.md) | [5,673](/filings/0002064953-26-000087.md) | [5,748](/filings/0002064953-26-000047.md) | [5,918](/filings/0002064953-26-000087.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [1,083](/filings/0002064953-26-000008.md) | not reported | not reported | [1,226](/filings/0002064953-25-000018.md) | [1,713](/filings/0002064953-26-000087.md) | [1,705](/filings/0002064953-26-000047.md) | [1,760](/filings/0002064953-26-000087.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [1,822](/filings/0002064953-26-000008.md) | not reported | not reported | [2,066](/filings/0002064953-25-000018.md) | [4,296](/filings/0002064953-26-000087.md) | [4,275](/filings/0002064953-26-000047.md) | [4,330](/filings/0002064953-26-000087.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0002064953-26-000008.md) | not reported | not reported | not reported | [1,968](/filings/0002064953-26-000087.md) | [1,965](/filings/0002064953-26-000047.md) | [1,966](/filings/0002064953-26-000087.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0002064953-26-000008.md) | not reported | not reported | not reported | [4.0](/filings/0002064953-26-000087.md) | [6.0](/filings/0002064953-26-000047.md) | [6.0](/filings/0002064953-26-000087.md) |
| Shareholders' equity | $m | [2,718](/filings/0002064953-26-000008.md) | [3,028](/filings/0002064953-26-000008.md) | [3,134](/filings/0002064953-25-000018.md) | [3,217](/filings/0002064953-25-000018.md) | [3,258](/filings/0002064953-26-000008.md) | [3,229](/filings/0002064953-26-000087.md) | [3,473](/filings/0002064953-26-000087.md) | [3,228](/filings/0002064953-25-000018.md) | [1,411](/filings/0002064953-26-000087.md) | [1,486](/filings/0002064953-26-000047.md) | [1,586](/filings/0002064953-26-000087.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [275 d](/filings/0002064953-26-000008.md) | [160](/filings/0002064953-26-000047.md) | [150 d](/filings/0002064953-26-000087.md) | [(21.0) d](/filings/0002064953-25-000018.md) | [166 d](/filings/0002064953-26-000008.md) | [199](/filings/0002064953-26-000047.md) | [262 d](/filings/0002064953-26-000087.md) |
| Capital expenditure | $m | [95.0 d](/filings/0002064953-26-000008.md) | [62.0](/filings/0002064953-26-000047.md) | [76.0 d](/filings/0002064953-26-000087.md) | [110 d](/filings/0002064953-25-000018.md) | [88.0 d](/filings/0002064953-26-000008.md) | [75.0](/filings/0002064953-26-000047.md) | [138 d](/filings/0002064953-26-000087.md) |
| Dividends paid | $m | not reported | [0.0](/filings/0002064953-26-000047.md) | [0.0 d](/filings/0002064953-26-000087.md) | not reported | not reported | [12.0](/filings/0002064953-26-000047.md) | [12.0 d](/filings/0002064953-26-000087.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [159](/filings/0002064953-26-000047.md) | [159](/filings/0002064953-26-000087.md) | [159](/filings/0002064953-26-000047.md) | [159](/filings/0002064953-26-000087.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 158,847,369 at 2026-07-23, from the cover of the [10-Q filed 2026-07-30](/filings/0002064953-26-000087.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.